KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) EPS (Basic): 2017-2025

Historic EPS (Basic) for Moderna (MRNA) over the last 8 years, with Sep 2025 value amounting to -$0.51.

  • Moderna's EPS (Basic) fell 1800.00% to -$0.51 in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.07, marking a year-over-year decrease of 38.90%. This contributed to the annual value of -$9.28 for FY2024, which is 24.74% up from last year.
  • Per Moderna's latest filing, its EPS (Basic) stood at -$0.51 for Q3 2025, which was up 76.06% from -$2.13 recorded in Q2 2025.
  • In the past 5 years, Moderna's EPS (Basic) ranged from a high of $12.06 in Q4 2021 and a low of -$9.53 during Q3 2023.
  • Over the past 3 years, Moderna's median EPS (Basic) value was -$2.52 (recorded in 2025), while the average stood at -$2.44.
  • As far as peak fluctuations go, Moderna's EPS (Basic) soared by 2,335.48% in 2021, and later crashed by 1,800.00% in 2025.
  • Quarterly analysis of 5 years shows Moderna's EPS (Basic) stood at $12.06 in 2021, then slumped by 68.08% to $3.85 in 2022, then slumped by 85.45% to $0.56 in 2023, then crashed by 619.64% to -$2.91 in 2024, then plummeted by 1,800.00% to -$0.51 in 2025.
  • Its last three reported values are -$0.51 in Q3 2025, -$2.13 for Q2 2025, and -$2.52 during Q1 2025.